NIH-funded research NIH-funded research

XenCAT: Single Cell Atlas for Xenopus

Official title: XenCAT: Xenopus Single Cell Atlas

Funded at Beth Israel Deaconess Medical Center · NIH-11594482 · Data updated 2026-11-12

Aims to map gene activity at the single-cell level in Xenopus to help understand how cells develop and how this relates to human disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 14, 2026
Project endJuly 31, 2027
Funding year2025
Award (this year)$691,785
NIH project number7R24OD031956-05
Project IDNIH-11594482 on NIH RePORTER

Who could benefit from this research

Could help

Researchers and clinicians who study human diseases may benefit from the cross-species cellular insights the atlas provides.

Less likely to help

Patients are unlikely to be directly involved or immediately benefit from the project.

What this research studies

This project will build a cell-by-cell map of gene activity in the Xenopus model to study how cells organize themselves during development. By creating a single-cell atlas and comparing it with other species, researchers hope to reveal how cellular programs go awry in disease and how predictable models can be built for therapy testing. The work involves advanced sequencing, data integration, and collaboration with model-organism and human genomics researchers to interpret functional cell networks. The atlas will serve as a resource for scientists to explore how genes work together across contexts that resemble human biology. Outcomes may inform better disease models and potential therapeutic strategies in the future.

Why it matters

Potential benefit: If successful, the atlas could accelerate understanding of how cell-level gene networks contribute to human diseases and improve disease modeling.

How similar studies have gone: Other single-cell atlases in model organisms have improved our understanding of development and disease; Xenopus-specific atlas work is an expansion of this approach.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Peshkin, Leon — Beth Israel Deaconess Medical Center
  • Study coordinator: Peshkin, Leon

Related research

Other NIH-funded projects on the same topics.

  • SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers

    This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625633

  • Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study

    This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625632

  • Statin use after brain bleed: SATURN MRI ancillary study

    This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625628

  • Statin use after lobar intracerebral hemorrhage

    This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518526

  • Statin use after lobar brain hemorrhage

    This trial compares stopping versus continuing statin medicine in people who had a lobar brain bleed to learn effects on repeat bleeding and future heart or stroke events.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518525

  • Minimally Invasive Sampling to Improve HIV-Associated M meningitis Diagnosis in Africa

    A research study is testing easier, less invasive ways to diagnose meningitis in people living with HIV, with a focus on making diagnosis faster and more accurate in Africa and the US.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11516017

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.